Softgel Capsules Market

Softgel Capsules Market Analysis and Forecast by Fact.MR

• The global market for softgel capsules is estimated to be around US$ 2.10 billion in 2025 and has been forecast to expand at a CAGR of 6.9% to end up at US$ 4.37 by 2036.
• Softgel capsules are single-piece, hermetically sealed dosage forms consisting of a gelatin or plant-based shell encapsulating liquid, semi-solid, or paste fill materials.
• Product types include gelatin-based softgels using bovine or porcine gelatin, and vegetarian softgels using plant-derived polymers such as modified starch and carrageenan. Applications span nutraceutical supplements, pharmaceutical drug delivery, functional foods, and cosmetic products.
• Growth is supported by consumer preference for easy-to-swallow dosage forms, superior bioavailability of liquid-fill formulations, expanding nutraceutical supplement consumption, pharmaceutical reformulation of existing drugs into softgel formats, and growing demand for vegetarian and halal-certified capsule alternatives.

Summary of Softgel Capsules Market

• Market Snapshot
  • In 2025, the global Softgel Capsules Market was valued at approximately USD 2.10 billion.
  • The market is estimated to reach USD 2.24 billion in 2026 and is projected to attain USD 4.37 billion by 2036.
  • The softgel capsules market is likely to expand at a CAGR of 6.9% during the forecast period.
  • The market is anticipated to create an absolute dollar opportunity of USD 2.13 billion between 2026 and 2036.
  • Gelatin Based Softgel Capsules account for 63.5% of product share in 2026.
  • India (7.9%) and China (7.6%) are the key growth markets during the forecast period.
• Demand and Growth Drivers
  • Growing consumer preference for easy to swallow dosage forms is augmenting the adoption of softgel in nutraceutical supplements.
  • Liquid-fill softgel formulation provides better bioavailability than tablet and hard capsule alternatives.
  • Growing demand for vegetarian and halal-certified softgel alternatives, expanding the addressable consumer base.
  • Technology improvements in gelatin based softgel capsules are improving performance and expanding commercially viable applications.
  • Market access is improving with increasing availability through direct and distributor channels.
• Product and Segment View
  • In 2026, gelatin-based softgel capsules are estimated to account for 63.5% of the market.
  • The dominant use case is Nutraceutical Applications, which accounted for 38.6% share in 2026.
  • Key segmentation includes:
    • Product: Gelatin Based Softgel Capsules, Vegetarian Softgel Capsules
    • Fill Material: Liquid Fill Formulations, Semi Solid Fill Formulations
    • Application: Nutraceutical Applications, Pharmaceutical Applications, Functional Food Applications, Cosmetic Applications
    • These systems enable:
      • Application-specific performance across diverse operating conditions.
      • Integration with monitoring, control, and automation platforms.
      • Reliable operation in environments requiring continuous or unattended use.
• Geography and Competitive Outlook
  • North America remains a leading regional market.
  • Europe maintains steady demand driven by regulatory standards and technology adoption.
  • Asia Pacific is emerging as a high-growth region.
  • India (7.9%) and China (7.6%) are the key growth markets, with Brazil and USA also contributing.
  • Key companies include Ethicon, Inc. (Johnson & Johnson), Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Chemence Medical, Inc., CryoLife, Inc., GluStitch Inc., Adhezion Biomedical, LLC (H.B. Fuller), Advanced Medical Solutions Group plc, Toagosei Co., Ltd., Cardinal Health, Inc..
• Analyst Opinion
  • Shambhu Nath Jha, Principal Consultant at Fact.MR, says 'The softgel capsules market is a mature dosage form category that continues to grow because of the inherent advantages of liquid-fill encapsulation for bioavailability, consumer compliance, and product differentiation. The competitive landscape includes both integrated softgel manufacturers and contract development and manufacturing organizations (CDMOs) that serve nutraceutical and pharmaceutical brand owners. The growth opportunity is concentrated in vegetarian softgel development, pharmaceutical reformulation programs, and contract manufacturing expansion. Companies that combine encapsulation technology expertise with regulatory compliance capability and flexible manufacturing capacity will capture the broadest customer base.'

Key Growth Drivers, Constraints, and Opportunities

Key Factors Driving Growth

• The nutraceutical supplement market is experiencing increased adoption of softgels due to consumer preference for easy-to-swallow dosage forms.
• Liquid-fill softgel formulation provides better bioavailability than tablet and hard capsule alternatives.
• Expanding the consumer base with a growing need for vegetarian and halal-certified softgel alternatives.

Key Market Constraints

• The higher manufacturing cost of softgels relative to tablets and hard capsules is a limiting factor for adoption in price sensitive markets.
• Sensitivity of the gelatin supply chain to availability of raw materials and religious and dietary restrictions
• Stability constraints of some active principles in softgel formulations with liquid fillers.

Key Opportunity Areas

• Development of vegetarian softgels with plant-sourced polymers to meet dietary, religious and ethical consumer needs.
• Conversion of existing oral drugs to softgel formulations for better patient compliance.
• Rising contract manufacturing as nutraceutical and pharmaceutical companies outsource softgel production to specialized CDMOs.

Segment-wise Analysis of the Softgel Capsules Market

• Gelatin Based Softgel Capsules hold 63.5% of the product type segment in 2026.
• Nutraceutical Applications represents 38.6% of the application segment in 2026.
• Vegetarian Softgel Capsules are growing faster in percentage terms, with share projected to rise.

The softgel capsules market is segmented by product, fill material, application, end use, technology, distribution channel, and region. By product type, the market covers gelatin based softgel capsules, vegetarian softgel capsules. By application, coverage includes nutraceutical applications, pharmaceutical applications, functional food applications, cosmetic applications.

Which Product Type Segment Dominates the Softgel Capsules Market?

Gelatin Based Softgel Capsules account for 63.5% of the total market value in 2026. Their leadership is supported by established use across mainstream applications, broad availability, and consistent demand.

The category continues to see broad adoption across nutraceutical applications and pharmaceutical applications applications.

Which Application Segment Dominates the Softgel Capsules Market?

Nutraceutical Applications is expected to be the dominant application segment with 38.6% of the total market value in 2026.

The segment is expected to consolidate its leadership. Pharmaceutical Applications will remain meaningful but its relative contribution is expected to stabilize.

Which Product Trend is Shaping the Next Phase of Growth in the Softgel Capsules Market?

Vegetarian softgel capsules are the fastest-growing segment as consumer demand for plant-based, halal-certified, and gelatin-free products expands across nutraceutical, pharmaceutical, and cosmetic applications. Vegetarian softgels using modified starch, carrageenan, and other plant-derived polymers address the dietary, religious, and ethical preferences of a growing global consumer base.

This shift towards vegetarian softgels highlights the structural change in consumer health product preferences, with plant-based formulations moving from niche to mainstream shelf presence. Those producers who develop plant-based shell technology, achieve price parity with gelatin-based products and offer the same fill compatibility and shelf stability will take the fastest-growing segment of the market. The greatest flexibility for brand customers targeting diverse consumer demographics is provided by contract manufacturers (CDMOs) with both gelatin and vegetarian softgel lines from the same production platform.

Regional Outlook Across Key Markets

• India leads growth at 7.9%, supported by industrial expansion, government infrastructure programs, and growing domestic consumption.
• China shows steady demand at 7.6%, supported by large-scale manufacturing activity, domestic demand expansion, and infrastructure investment programs.
• Brazil shows steady demand at 7.5%, supported by energy sector expansion and infrastructure development programs.
• USA shows steady demand at 7.4%, supported by a large installed base, established distribution channels, and strong end-use industry activity.

CAGR Table

Source: Fact MR (FMR) analysis, based on proprietary forecasting model and primary research.

Market Outlook for Softgel Capsules in India

The India softgel capsules market is projected to grow at a CAGR of 7.9% through 2036. Demand is supported by industrial expansion, government infrastructure programs, and growing domestic consumption.

• Industrial expansion drives first-time equipment procurement.
• Government infrastructure programs support institutional demand.
• Cost sensitivity favors manufacturers with competitive pricing.

Softgel Capsules Demand Trends in China

The China softgel capsules market is projected to grow at a CAGR of 7.6% through 2036. Demand is supported by large-scale manufacturing activity, domestic demand expansion, and infrastructure investment programs.

• Domestic manufacturing scale supports pricing competitiveness.
• Infrastructure investment programs create sustained demand.
• Technology adoption is accelerating across industrial applications.

Brazil Softgel Capsules Market Growth Outlook

The Brazil softgel capsules market is projected to grow at a CAGR of 7.5% through 2036. Demand is supported by energy sector expansion and infrastructure development programs.

• Infrastructure development programs support new installations.
• Energy sector expansion drives equipment procurement.
• Regional manufacturing presence reduces logistics costs.

USA Softgel Capsules Market Demand Analysis

The U.S. softgel capsules market is projected to grow at a CAGR of 7.4% through 2036. Demand is supported by a large installed base, established distribution channels, and strong end-use industry activity.

• Large installed base supports steady replacement demand.
• Premium product adoption is higher than global average.
• Established distribution networks maintain broad market access.

Japan Softgel Capsules Market Growth Assessment

The Japan softgel capsules market is projected to grow at a CAGR of 7.3% through 2036. Demand is supported by quality-focused procurement, aging infrastructure replacement, and precision manufacturing demand.

• Quality-focused procurement supports premium product segments.
• Aging infrastructure creates replacement and modernization demand.
• Domestic precision standards influence specifications.

Softgel Capsules Market Opportunity in UK

The UK softgel capsules market is projected to grow at a CAGR of 7.2% through 2036. Demand is supported by steady institutional demand and growing connected product adoption.

• Institutional demand provides a stable procurement base.
• Connected product adoption is increasing among commercial buyers.
• Regulatory standards support higher-specification equipment.

Germany Softgel Capsules Demand and Growth Drivers

The Germany softgel capsules market is projected to grow at a CAGR of 7% through 2036. Demand is supported by engineering-grade procurement standards, export manufacturing, and steady replacement cycles.

• Engineering standards drive demand for precision-grade equipment.
• Export-oriented manufacturing base supports domestic procurement.
• Regulatory compliance requirements favor certified suppliers.

Competitive Benchmarking and Company Positioning

Softgel Capsules Market Analysis By Company

• Ethicon, Inc. (Johnson & Johnson), Medtronic plc, Baxter International Inc., B. Braun Melsungen AG hold established positions in the global softgel capsules market.
• Chemence Medical, Inc., CryoLife, Inc., GluStitch Inc., Adhezion Biomedical, LLC (H.B. Fuller) participate across specific segments and geographic markets.
• Technology integration and service capability are increasingly important differentiators.

The competitive landscape is moderately fragmented. Ethicon, Inc. (Johnson & Johnson), Medtronic plc, Baxter International Inc., B. Braun Melsungen AG compete through product breadth, technical capability, and distribution reach.

• Chemence Medical, Inc., CryoLife, Inc., GluStitch Inc., Adhezion Biomedical, LLC (H.B. Fuller) maintain relevance across specific customer groups.
• Advanced Medical Solutions Group plc, Toagosei Co., Ltd., Cardinal Health, Inc. compete through focused offerings.

Key Companies in the Softgel Capsules Market

• Ethicon, Inc. (Johnson & Johnson), Medtronic plc, Baxter International Inc., B. Braun Melsungen AG are among the leading players globally.
• Chemence Medical, Inc., CryoLife, Inc., GluStitch Inc., Adhezion Biomedical, LLC (H.B. Fuller) hold established positions across key segments.
• Advanced Medical Solutions Group plc, Toagosei Co., Ltd., Cardinal Health, Inc. compete through focused offerings.

Recent Industry Developments

• Catalent, Inc., Softgel Manufacturing Capacity Expansion (January 2026)
  • Catalent continued expanding softgel manufacturing capabilities supporting both gelatin and plant-based formulations for pharmaceutical and nutraceutical applications.
• Aenova Group, Vegetarian Softgel Technology Development (2025)
  • Aenova advanced its plant-based softgel encapsulation technology with improved shell formulations and expanded fill compatibility, supporting growing demand for vegetarian capsule alternatives across European and North American markets.
• Patheon (Thermo Fisher Scientific), Pharmaceutical Softgel Reformulation Services (2025)
  • Patheon continued strengthening formulation and manufacturing services for pharmaceutical softgel applications focused on bioavailability optimization.
• Procaps Group, Softgel Innovation and Market Expansion (February 2026)
  • Procaps continued expanding softgel manufacturing and delivery-system capabilities for nutraceutical and pharmaceutical customers.

Leading Companies Shaping the Softgel Capsules Market

• Ethicon, Inc. (Johnson & Johnson)
• Medtronic plc
• Baxter International Inc.
• B. Braun Melsungen AG
• Chemence Medical, Inc.
• CryoLife, Inc.
• GluStitch Inc.
• Adhezion Biomedical, LLC (H.B. Fuller)
• Advanced Medical Solutions Group plc
• Toagosei Co., Ltd.
• Cardinal Health, Inc.

Sources and Research References

• Ethicon, Inc. (Johnson & Johnson). Product portfolio updates and market activity.
• Medtronic plc. Product portfolio updates and market activity.
• Baxter International Inc.. Product portfolio updates and market activity.
• Industry association statistics, regulatory publications, and trade data.
• Primary interviews with manufacturers, operators, and end users.

This bibliography is provided for reader reference and is not exhaustive.

Key Questions This Report Addresses

• What is the current and future size of the Softgel Capsules Market?
• How fast is the softgel capsules market expected to grow between 2026 and 2036?
• Which product type is likely to lead the market by 2026?
• Which application segment is expected to account for the highest demand by 2026?
• What factors are driving demand globally?
• How is the shift toward advanced configurations influencing the market?
• Why is India emerging as the fastest-growing market?
• Which countries are projected to show the fastest growth through 2036?
• Who are the key companies active in the Softgel Capsules Market?
• How does Fact.MR estimate and validate the market forecast?

Softgel Capsules Market Definition

The softgel capsules market covers single-piece hermetically sealed dosage forms with gelatin or plant-based shells encapsulating liquid or semi-solid fills for nutraceutical, pharmaceutical, functional food, and cosmetic applications. It includes regional and global market size and forecasts for 2026 to 2036.

Softgel Capsules Market Inclusions

• The scope covers global and regional market size and forecasts for 2026 to 2036 across product, fill material, application, end use, technology, distribution channel, and region.
• It includes regional demand analysis across major geographies.
• The report includes pricing and cost analysis across entry-level, mid-range, and premium offerings.
• It covers technology trends, market drivers and constraints, and the competitive landscape.

Softgel Capsules Market Exclusions

• The scope excludes products not purpose-built for the defined application scope.
• It excludes standalone software platforms and services sold independently.
• The report excludes custom-built non-commercial systems with limited market visibility.

Softgel Capsules Market Research Methodology

• The methodology combines secondary research, primary interviews, and forecast modelling.
• It draws on 120+ secondary sources and benchmarks 65+ company portfolios.
• Market sizing covers 30+ countries through a demand-side model with top-down validation.
• Key inputs are end-use activity, infrastructure spending, technology adoption and regulatory conditions.
• The model cross-checks demand against shipments, pricing, channel mix and product launches.
• Primary validation includes 25+ interviews with manufacturers, operators and end users.
• Final estimates are subject to trade-flow checks, sales-pattern review and sensitivity testing.